| Name | WYC-210 |
|---|
| Description | WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1]. |
|---|---|
| Related Catalog | |
| In Vitro | WYC-210 (10 μM; 5 days) inhibits cell growth of B16-F1 TRC cells with an inhibition rate of 18.1%[1]. |
| References |
| Molecular Formula | C18H16N2O3S |
|---|---|
| Molecular Weight | 340.40 |
| Storage condition | 2-8°C |